KOBAYASHI PHARMACEUTICAL CO.,LTD.

4967

TSE PrimeChemicals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-06FY2026 Q2

Revenue

1674.7100M JPY

YoY +3.7%

Operating Income

21.6100M JPY

YoY -67.5%

Net Income

16.3100M JPY

YoY -86.2%

EPS

15.3JPY

YoY -64.1%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

1734.5億円

1300.9億円

867.3億円

433.6億円

Rev: 1552.5億円Op: 260.6億円NI: 197.2億円

Rev: 1662.6億円Op: 266.7億円NI: 200.2億円

Rev: 1734.5億円Op: 257.8億円NI: 203.4億円

Rev: 1656億円Op: 248.6億円NI: 100.7億円

Rev: 1657.4億円Op: 149.2億円NI: 36.6億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income11.4%

Revenue Progress707.500M

Revenue Forecast173000M

Net Income Progress11.400M

Net Income Forecast10000M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan